TP53 and endometrial cancer: If the molecular subtype is known, abnormal p53 endometrial cancer confined to the uterine corpus with any myometrial invasion, with or without cervical invasion, and regardless of the degree of lymphovascular invasion or the histological type, is classified as Stage 2Cmp53abn in FIGO 2023 staging [5].